Focused on the global commercialization strategy, including pricing, reimbursement, market access, and patient engagement for rare diseases, while ensuring therapies reach patients effectively, drive revenue growth, and support long-term market sustainability.
Focused on the design, execution, and monitoring of clinical trials, working closely with CROs and internal teams to advance CNS-targeted therapies, while ensuring trials meet regulatory standards, generate reliable data, and support the scientific and medical strategy of DCRM Sciences.